Table 2—

Baseline demographic characteristics and efficacy variables of the PP population

CharacteristicNo self-monitoringSelf-monitoringP
Age (years)60.5 ± 6.658.7 ± 7.60.3846
Gender
 Female (%)48.247.80.8546
 Male (%)51.852.2
Duration of diabetes (months)62.6 ± 47.365.5 ± 57.20.5335
Body weight (kg)89.6 ± 16.588.2 ± 15.40.3810
BMI (kg/m2)31.9 ± 5.531.0 ± 4.60.5224
HbA1c (%)8.35 ± 0.758.47 ± 0.860.8535
Total cholesterol (mg/dl)227.5 ± 52.5221.1 ± 41.20.3277
Triglycerides (mg/dl)237.4 ± 192.8204.2 ± 133.30.2966
Microalbumin (mg/l)44.5 ± 63.442.7 ± 68.30.5305
Treatment satisfaction score27.0 ± 6.627.6 ± 7.10.5006
General well-being total score26.5 ± 5.926.4 ± 5.40.8576
  • Data are means ± SD.